The DOI matches its Crossref record; 183 of the 186 references it cites were found in a registry or an index.
Nicotinic receptors in human brain: topography and pathology
Open accessAbstract
Brain nicotinic acetylcholine receptors (nAChR) are a class of ligand-gated channels composed of alpha and beta subunits with specific structural, functional and pharmacological properties. They participate in the physiological and behavioural effects of acetylcholine and mediate responses to nicotine. They are associated with numerous transmitter systems and their expression is altered during development and ageing as well as in diseases such as autism, schizophrenia, Alzheimer's disease, Parkinson's disease and Lewy body dementia. Nicotinic receptors containing a number of different subunits are highly expressed during early human development. Disorders believed to be associated with abnormal brain maturation involve deficits in both alpha4beta2, in the case of autism, and alpha7 possibly in addition to alpha4beta2 nAChRs in the case of schizophrenia. In ageing and age-related neurodegenerative disorders nAChR deficits are predominantly associated with alpha4-containing receptors, although some studies also indicate the involvement of alpha3 and alpha7 subunits. Whilst ageing appears to be associated with reductions in subunit mRNA as well as protein expression, in Alzheimer's disease only protein loss is apparent. Nicotinic therapy may be of benefit in a number of neurological conditions, however studies evaluating further both the distribution of specific subunit involvement and the correlation of nAChR deficits with clinical symptoms are required to inform therapeutic strategy.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The heteromeric a4b2* subtype and the homomeric a7 are the most prevalent receptor subtypes in the central nervous system (Court et al., 2000).”
From Activation of α4β2*/α6β2* nicotinic receptors alleviates anxiety during nicotine withdrawal without upregulating nicotinic receptors (2014) · cites this paper as Court et al., 2000
Citations
Cites
McKeith, I. G., Galasko, D., Kosaka, K., Perry, E. K., Dickson, D. W., Hansen, L. A., Salmon, D. P., Lowe, J., Mirra, S. S., Byrne, E. J., et al. (1996) · Neurology · doi:10.1212/wnl.47.5.1113 · Cited by 3,960
Self-citationSELECTIVE LOSS OF CENTRAL CHOLINERGIC NEURONS IN ALZHEIMER'S DISEASE
DAVIES, P. (1976) · The Lancet · doi:10.1016/s0140-6736(76)91936-x · Cited by 3,565
A rapid radiochemical method for the determination of choline acetyltransferase
Fonnum, F. (1975) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1975.tb11895.x · Cited by 2,358
Picciotto, M. R., Zoli, M., Rimondini, R., Léna, C., Marubio, L. M., Pich, E. M., Fuxe, K., & Changeux, J.-P. (1998) · Nature · doi:10.1038/34413 · Cited by 1,320
Presynaptic nicotinic ACh receptors
Wonnacott, S. (1997) · Trends in Neurosciences · doi:10.1016/s0166-2236(96)10073-4 · Cited by 1,308
Asher, R. (1961) · The Lancet · doi:10.1016/s0140-6736(61)91217-x · Cited by 1,293
Linkage of a neurophysiological deficit in schizophrenia to a chromosome 15 locus
Freedman, R., Coon, H., Myles-Worsley, M., Orr-Urtreger, A., Olincy, A., Davis, A., Polymeropoulos, M., Holik, J., Hopkins, J., Hoff, M., et al. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.2.587 · Cited by 1,141
Nicotine enhancement of fast excitatory synaptic transmission in CNS by presynaptic receptors
McGehee, D. S., Heath, M. J. S., Gelber, S., Devay, P., & Role, L. W. (1995) · Science · doi:10.1126/science.7569895 · Cited by 1,070
Physiological Diversity of Nicotinic Acetylcholine Receptors Expressed by Vertebrate Neurons
McGehee, D. S., & Role, L. W. (1995) · Annual Review of Physiology · doi:10.1146/annurev.ph.57.030195.002513 · Cited by 1,022
Frith, U., & Mira, M. P. (1992) · Focus on Autism and Other Developmental Disabilities · doi:10.1177/108835769200700302 · Cited by 900
Research works printed but not linked: 1
- Perry, 1989, Nicotine [3H-nicotine] receptor binding in human brain: characterization and involvement in cholinergic neuropathology, Neurosci. Res. Commun., 5, 117
Cited by
Sorted by citations
Items 101–180 of 180
[125I]Iodomethyllycaconitine binds to α7 nicotinic acetylcholine receptors in monkey brain
Kulak, J. M., Carroll, F. I., & Schneider, J. S. (2006) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2006.04804.x · Cited by 23
The nicotinic cholinergic system is affected in rats with delayed carbon monoxide encephalopathy
Ochi, S., Abe, M., Li, C., Mori, Y., Ishimaru, T., Yoshino, Y., Yamazaki, K., Mori, T., Fukuhara, R., Tanimukai, S., et al. (2014) · Neuroscience Letters · doi:10.1016/j.neulet.2014.03.054 · Cited by 23
Leblond, L., Beaufort, C., Delerue, F., & Durkin, T. (2002) · Behavioural Brain Research · doi:10.1016/s0166-4328(01)00306-0 · Cited by 23
Turner, J. R., Ortinski, P. I., Sherrard, R. M., & Kellar, K. J. (2011) · The Cerebellum · doi:10.1007/s12311-011-0285-y · Cited by 22
Regulatory mechanisms that govern nicotinic synapse formation in neurons
Rosenberg, M. M., Blitzblau, R. C., Olsen, D. P., & Jacob, M. H. (2002) · Journal of Neurobiology · doi:10.1002/neu.10112 · Cited by 22
In vitro and in vivo characterization of [125I]iodomethyllycaconitine in the rat
Navarro, H. A., Xu, H., Zhong, D., Abraham, P., & Carroll, F. I. (2002) · Synapse · doi:10.1002/syn.10062 · Cited by 22
Enhancement of nicotinic receptors alleviates cytotoxicity in neurological disease models
Kawamata, J., Suzuki, S., & Shimohama, S. (2011) · Therapeutic Advances in Chronic Disease · doi:10.1177/2040622310397691 · Cited by 17
Ogawa, M., Tsukada, H., Hatano, K., Ouchi, Y., Saji, H., & Magata, Y. (2009) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.32.337 · Cited by 21
Whole-body radiation dosimetry of 2-[18F]Fluoro-A-85380 in human PET imaging studies
Obrzut, S. L., Koren, A. O., Mandelkern, M. A., Brody, A. L., Hoh, C. K., & London, E. D. (2005) · Nuclear Medicine and Biology · doi:10.1016/j.nucmedbio.2005.06.005 · Cited by 21
Ellis, J. R., Nathan, P. J., Villemagne, V. L., Mulligan, R. S., Ellis, K. A., Tochon‐Danguy, H., Chan, J. G., O'Keefe, G., Bradley, J., Savage, G. R., et al. (2009) · Synapse · doi:10.1002/syn.20642 · Cited by 20
18F-XTRA PET for Enhanced Imaging of the Extrathalamic α4β2 Nicotinic Acetylcholine Receptor
Coughlin, J. M., Slania, S., Du, Y., Rosenthal, H. B., Lesniak, W. G., Minn, I., Smith, G. S., Dannals, R. F., Kuwabara, H., Wong, D. F., et al. (2018) · Journal of Nuclear Medicine · doi:10.2967/jnumed.117.205492 · Cited by 20
Using rodents to model schizophrenia and substance use comorbidity
Ng, E., McGirr, A., Wong, A. H. C., & Roder, J. (2013) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2013.03.025 · Cited by 19
Marshall‐Gradisnik, S., Johnston, S., Chacko, A., Nguyen, T. U., Smith, P. K., & Staines, D. (2016) · Journal of International Medical Research · doi:10.1177/0300060516671622 · Cited by 18
Functional neurochemistry of the basal ganglia
Samadi, P., Rouillard, C., Bédard, P. J., & Paolo, T. D. (2007) · Handbook of clinical neurology · doi:10.1016/s0072-9752(07)83002-8 · Cited by 17
Baradaran, R., Khoshdel‐Sarkarizi, H., Kargozar, S., Hami, J., Mohammadipour, A., Sadr‐Nabavi, A., Peyvandi, M., Kheradmand, H., & Haghir, H. (2020) · International Journal of Developmental Neuroscience · doi:10.1002/jdn.10026 · Cited by 17
Kim, S. W., Ding, Y., Alexoff, D. L., Patel, V. D., Logan, J., Lin, K., Shea, C. E., Muench, L., Xu, Y., Carter, P., et al. (2007) · Nuclear Medicine and Biology · doi:10.1016/j.nucmedbio.2007.04.005 · Cited by 17
Krivoshein, A. V., & Hess, G. P. (2003) · Biochemistry · doi:10.1021/bi034838l · Cited by 16
Hoffmann, C., Stevens, J., Zong, S., van Kruining, D., Saxena, A., Küçükali, C. İ., Tüzün, E., Yalçınkaya, N., Hert, M. D., González‐Vioque, E., et al. (2018) · PLoS ONE · doi:10.1371/journal.pone.0208412 · Cited by 14
Reinvang, I., Lundervold, A. J., Wehling, E. I., Rootwelt, H., & Espeseth, T. (2010) · Journal of the International Neuropsychological Society · doi:10.1017/s1355617710000263 · Cited by 14
Aguado, C., & Luján, R. (2018) · Neuromethods · doi:10.1007/978-1-4939-8985-0_6 · Cited by 11
The effects of transdermal nicotine on inspection time
Thompson, J. C., Wilby, G., & Stough, C. K. K. (2002) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/hup.377 · Cited by 11
Neural nAChRs PET imaging probes
Mo, Y.-X., Yin, Y., & Li, Y. (2013) · Nuclear Medicine Communications · doi:10.1097/mnm.0000000000000032 · Cited by 10
Ciliary neurotrophic factor enhances nicotinic synaptic transmission in sympathetic neurons
Nai, Q., Wang, X., Jin, Y. H., Sun, D., Li, M., Hu, B., & Zhang, X. (2009) · Journal of Neuroscience Research · doi:10.1002/jnr.22260 · Cited by 10
Viberg, H. (2004) · KTH Publication Database DiVA (KTH Royal Institute of Technology) · Cited by 10
Wu, J., Toyohara, J., Tanibuchi, Y., Fujita, Y., Zhang, J., Chen, H., Matsuo, M., Wang, R. F., & Hashimoto, K. (2010) · Brain Research · doi:10.1016/j.brainres.2010.08.095 · Cited by 9
Nicotine an efficient tool of the neurobiological research today, the tool of treatment tomorrow?
RILJAK, V., & Langmeier, M. (2005) · PubMed · Cited by 9
Smith, D., Fisher, D. J., Blier, P., Ilivitsky, V., & Knott, V. (2015) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2015.07.008 · Cited by 8
Cheffer, A., & Ulrich, H. (2011) · Biochemistry · doi:10.1021/bi101789y · Cited by 7
In vitro evidence supporting the therapeutic role of nicotine against neurodegeneration.
Williams, E., & Linert, W. (2004) · PubMed · Cited by 7
Understanding nicotine addiction and the health effects of nicotine use
Pöğün, Ş., & Arman, A. R. (2021) · European Respiratory Society eBooks · doi:10.1183/2312508x.10002020 · Cited by 6
Ueda, M., Iida, Y., Yoneyama, T., Kawai, T., Ogawa, M., Magata, Y., & Saji, H. (2010) · Synapse · doi:10.1002/syn.20819 · Cited by 7
Kulak, J. M., Fan, H., & Schneider, J. S. (2007) · Neurobiology of Disease · doi:10.1016/j.nbd.2007.06.004 · Cited by 6
The nACHR4 594C/T Polymorphism in Alzheimer Disease
Vasto, S., Candore, G., Aquino, A., Bulati, M., Balistreri, C. R., Grimaldi, M. P., Ditta, V., Colonna‐Romano, G., Lio, D., Vitello, S., et al. (2006) · Rejuvenation Research · doi:10.1089/rej.2006.9.107 · Cited by 6
A abstenção tabágica: Reflexões sobre a recaída
Guerra, M. P. (2012) · Análise Psicológica · doi:10.14417/ap.223 · Cited by 5
SPECT imaging of the a42 nicotinic receptor using [5-123I]A85380
Pimlott, S., Piggott, M., Patterson, J., Cavanagh, J., & Wyper, D. (2007) · Journal of Labelled Compounds and Radiopharmaceuticals · doi:10.1002/jlcr.1192 · Cited by 4
Pitti, A., & Kuniyoshi, Y. (2011) · International Joint Conference on Neural Networks (IJCNN) · doi:10.1109/ijcnn.2011.6033389 · Cited by 5
Molecular Imaging of 7 Nicotinic Acetylcholine Receptors In Vivo: Current Status and Perspectives
Brust, P., & Deuther‐Conrad, W. (2012) · InTech eBooks · doi:10.5772/23787 · Cited by 4
Sueyoshi, M., Harada, K., Okawa, M., Matsuhara, T., Ando, M., Araki, R., Minote, Y., Ishihara, K., Shimohama, S., & Takata, K. (2025) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.b25-00308 · Cited by 4
Functional Brain Imaging of Tobacco Exposure in Humans
Storage, S. S., & Brody, A. L. (2012) · Journal of Addiction Research & Therapy · doi:10.4172/2155-6105.s2-003 · Cited by 5
Garg, A., Chedrawi, A. K., Pardo, C. A., Johnston, M., & Menon, D. U. (2015) · Journal of Pediatric Neurology · doi:10.3233/jpn-140658 · Cited by 4
McCullumsmith, R. E., Semins, M. J., & Meador‐Woodruff, J. H. (2004) · Synapse · doi:10.1002/syn.20003 · Cited by 4
Dumont, F., Sultana, A., Balter, A., & Waterhouse, R. N. (2003) · Journal of Labelled Compounds and Radiopharmaceuticals · doi:10.1002/jlcr.785 · Cited by 4
Sobrio, F., Debruyne, D., Dhilly, M., Chazalviel, L., Camsonne, R., Kakiuchi, T., Tsukada, H., & Barré, L. (2005) · Neurochemistry International · doi:10.1016/j.neuint.2004.12.003 · Cited by 4
Sobrio, F., Quentin, T., Dhilly, M., Bourdier, T., Tymciu, S., Debruyne, D., & Barré, L. (2008) · Nuclear Medicine and Biology · doi:10.1016/j.nucmedbio.2007.11.011 · Cited by 4
Darreh‐Shori, T. (2006) · Figshare · Cited by 4
Escobar-Arriaga, E., Pérez-Bautista, O., Venegas, A. R., & Sansores, R. H. (2007) · Revista del Instituto Nacional de Enfermedades Respiratorias · Cited by 3
Molnár, E. (2016) · Neuromethods · doi:10.1007/978-1-4939-3064-7_12 · Cited by 3
Involvement of the recurrent artery of Heubner with contralateral middle cerebral artery infarction
Sharma, V. K., & Chan, B. (2006) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.2006.102046 · Cited by 3
α7-Nicotinic Acetylcholine Receptors and β-Amyloid Peptides in Alzheimer’s Disease
Lorke, D. E., Petroianu, G. A., & Öz, M. (2016) · Neuromethods · doi:10.1007/978-1-4939-3768-4_10 · Cited by 3
Ankarberg, E. H. (2003) · KTH Publication Database DiVA (KTH Royal Institute of Technology) · Cited by 3
Molnár, E. (2021) · Neuromethods · doi:10.1007/978-1-0716-1522-5_13 · Cited by 2
Chapter 1 Cholinergic components of frontal lobe function and dysfunction
Rabin, L. A., Tanapat, P., & Relkin, N. R. (2008) · Handbook of clinical neurology · doi:10.1016/s0072-9752(07)88001-8 · Cited by 2
Cheffer, A., Mustafa, E. V., do Amaral, A. T., & Ulrich, H. (2012) · Journal of Neuroscience Research · doi:10.1002/jnr.23047 · Cited by 2
α7 Nicotinic acetylcholine receptor-mediated anti-inflammatory actions modulate brain functions
(2016) · Neurotransmitter · doi:10.14800/nt.1303 · Cited by 2
Aguado, C., Martín‐Belmonte, A., Alfaro‐Ruiz, R., Moreno‐Martínez, A. E., & Luján, R. (2023) · PubMed · doi:10.14670/hh-18-581 · Cited by 2
Veljkovic, E., Xia, W., Phillips, B. W., Wong, E. T., Ho, J., Oviedo, A., Hoeng, J., & Peitsch, M. C. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-812922-7.00001-9 · Cited by 2
Fischer, C. (2008) · Uppsala University Publications (Uppsala University) · Cited by 2
Pitti, A., & Kuniyoshi, Y. (2013) · Springer eBooks · doi:10.1007/978-94-007-4792-0_96 · Cited by 1
Aliev, G. M., Li, Y., Palacios, H. H., Obrenovich, M. E., Bragin, V., Bragin, I., Shevtsova, E. F., Klochkov, S. G., Kosenko, E. A., Cacabelos, R., et al. (2011) · Springer eBooks · doi:10.1007/978-3-642-30018-9_208 · Cited by 1
Khaled, S. M. (2011) · Libraries and Cultural Resources (University of Calgary) · doi:10.11575/prism/12876 · Cited by 1
Haubner, A. J. (2008) · UKnowledge (University of Kentucky)
TSUTSUI, Y. (2003) · Japanese Journal of Animal Psychology · doi:10.2502/janip.53.57
Falk, L. L. (2005) · Figshare
REVIEW ARTICLE Alzheimer’s disease and anaesthesia: implications for the central cholinergic system
Fodale, V., Quattrone, D., Trecroci, C., Caminiti, V., & Santamaria, L. B. (2006)
Baluchnejadmojarad, T., Roghani, M., Karimi, N., & Kamran, M. (2011) · DOAJ (DOAJ: Directory of Open Access Journals)
Nicotine : Pharmacology and therapeutic implications in neurodegenerative and psychiatric disorders
Scerri, C. (2005) · OAR@UM (University of Malta)
Paraoxonase 1 Status, Environmental Exposures, and Oxidative Stress in Autism Spectrum Disorders
Dronca, M., & Pașca, S. P. (2009) · CRC Press eBooks · doi:10.1201/9781420068870-c6
Lana, D. (2016) · Premio Tesi dottorato/Premio Tesi di dottorato · doi:10.36253/978-88-6655-941-2
Tyagi, E. (2011) · Shodhganga
Cholinergic modulation of antisaccade performance
Petrovsky, N. (2012) · bonndoc (University of Bonn)
(2018) · Elsevier eBooks · doi:10.1016/b978-0-12-812922-7.09994-7
Investigating α7 nicotinic receptor STAT3 signaling and cell-dependent expression
Koperniak, T. M. (2012) · doi:10.17760/d20002968
Munafo, M. R., & Grabski, M. (2020) · doi:10.1093/med/9780198713005.003.0055
Sheets, L. P., Patel, M., Zorrilla, L. M., & Bothe, K. (2026) · Regulatory Toxicology and Pharmacology · doi:10.1016/j.yrtph.2026.106040
Metadata
- Authors
- Court, J. A., Martin-Ruiz, C., Graham, A., & Perry, E.
- Affiliations
- Newcastle University (GB)
- Corresponding author
- Court, Jenny A.
- ORCID
- Martin-Ruiz, Carmen
- Venue
- Journal of Chemical Neuroanatomy
- Publisher
- Elsevier BV
- Published
- 2000-12
- Volume
- 20
- Issue
- 3-4
- Pages
- 281-298
- ISSN
- 0891-0618 (ISSN-L)
- OpenAlex
- W1967131207
- Cited by
- 180
- References
- 186
- Citations by year
- 2026: 1 · 2025: 2 · 2023: 4 · 2022: 1 · 2021: 4 · 2020: 2 · 2019: 1 · 2018: 9 · 2017: 2 · 2016: 6 · 2015: 8 · 2014: 5 · 2013: 6 · 2012: 8
- FWCI
- 0.69
- Type
- journal article
- Language
- en
- Open access
- green
- doi.org
- Locations
- Journal of Chemical Neuroanatomy (publishedVersion)
- PubMed (publishedVersion)
- Newcastle University ePrints (Newcastle Univesity)
- Funders
- Eli Lilly and Company
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Nicotinic Acetylcholine Receptors Study
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Smoking Behavior and Cessation
- Keywords
- nicotinic acetylcholine receptors, human brain, receptor subunit expression, alpha4beta2 nAChR, alpha7 nAChR, brain development, brain aging, neurodegeneration, autism spectrum disorder, schizophrenia, Alzheimer's disease, Parkinson's disease, dementia with Lewy bodies
- MeSH terms
- Brain Chemistry, Brain Diseases, Humans, Receptors, Nicotinic
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review